SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-004059
Filing Date
2023-01-09
Accepted
2023-01-09 06:09:50
Documents
56
Period of Report
2023-01-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d398949d8k.htm   iXBRL 8-K 25992
2 EX-99.1 d398949dex991.htm EX-99.1 23638
3 EX-99.2 d398949dex992.htm EX-99.2 55948
7 GRAPHIC g398949ex99_2p10g1.jpg GRAPHIC 311364
8 GRAPHIC g398949ex99_2p11g1.jpg GRAPHIC 226548
9 GRAPHIC g398949ex99_2p12g1.jpg GRAPHIC 341471
10 GRAPHIC g398949ex99_2p13g1.jpg GRAPHIC 212655
11 GRAPHIC g398949ex99_2p14g1.jpg GRAPHIC 102668
12 GRAPHIC g398949ex99_2p15g1.jpg GRAPHIC 361066
13 GRAPHIC g398949ex99_2p16g1.jpg GRAPHIC 293447
14 GRAPHIC g398949ex99_2p17g1.jpg GRAPHIC 292043
15 GRAPHIC g398949ex99_2p18g1.jpg GRAPHIC 402369
16 GRAPHIC g398949ex99_2p19g1.jpg GRAPHIC 267261
17 GRAPHIC g398949ex99_2p1g1.jpg GRAPHIC 99328
18 GRAPHIC g398949ex99_2p20g1.jpg GRAPHIC 321687
19 GRAPHIC g398949ex99_2p21g1.jpg GRAPHIC 273673
20 GRAPHIC g398949ex99_2p22g1.jpg GRAPHIC 70853
21 GRAPHIC g398949ex99_2p23g1.jpg GRAPHIC 324830
22 GRAPHIC g398949ex99_2p24g1.jpg GRAPHIC 378374
23 GRAPHIC g398949ex99_2p25g1.jpg GRAPHIC 307836
24 GRAPHIC g398949ex99_2p26g1.jpg GRAPHIC 56731
25 GRAPHIC g398949ex99_2p27g1.jpg GRAPHIC 248694
26 GRAPHIC g398949ex99_2p28g1.jpg GRAPHIC 254607
27 GRAPHIC g398949ex99_2p29g1.jpg GRAPHIC 330927
28 GRAPHIC g398949ex99_2p2g1.jpg GRAPHIC 599358
29 GRAPHIC g398949ex99_2p30g1.jpg GRAPHIC 236818
30 GRAPHIC g398949ex99_2p31g1.jpg GRAPHIC 245644
31 GRAPHIC g398949ex99_2p32g1.jpg GRAPHIC 291164
32 GRAPHIC g398949ex99_2p33g1.jpg GRAPHIC 236598
33 GRAPHIC g398949ex99_2p34g1.jpg GRAPHIC 287190
34 GRAPHIC g398949ex99_2p35g1.jpg GRAPHIC 435247
35 GRAPHIC g398949ex99_2p36g1.jpg GRAPHIC 293740
36 GRAPHIC g398949ex99_2p37g1.jpg GRAPHIC 350671
37 GRAPHIC g398949ex99_2p38g1.jpg GRAPHIC 312671
38 GRAPHIC g398949ex99_2p39g1.jpg GRAPHIC 208119
39 GRAPHIC g398949ex99_2p3g1.jpg GRAPHIC 336531
40 GRAPHIC g398949ex99_2p40g1.jpg GRAPHIC 251718
41 GRAPHIC g398949ex99_2p41g1.jpg GRAPHIC 371726
42 GRAPHIC g398949ex99_2p4g1.jpg GRAPHIC 361187
43 GRAPHIC g398949ex99_2p5g1.jpg GRAPHIC 268956
44 GRAPHIC g398949ex99_2p6g1.jpg GRAPHIC 82672
45 GRAPHIC g398949ex99_2p7g1.jpg GRAPHIC 395776
46 GRAPHIC g398949ex99_2p8g1.jpg GRAPHIC 318488
47 GRAPHIC g398949ex99_2p9g1.jpg GRAPHIC 306627
48 GRAPHIC g398949g0108103439844.jpg GRAPHIC 3020
  Complete submission text file 0001193125-23-004059.txt   16341422

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dawn-20230108.xsd EX-101.SCH 2855
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dawn-20230108_lab.xml EX-101.LAB 18736
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dawn-20230108_pre.xml EX-101.PRE 11710
50 EXTRACTED XBRL INSTANCE DOCUMENT d398949d8k_htm.xml XML 3485
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94080-1930
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94080-1930 650 484-0899
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40431 | Film No.: 23516424
SIC: 2834 Pharmaceutical Preparations